Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sterogene Bioseparations is a private life science tools and bioprocessing company that develops and manufactures chromatography resins and related purification products for biopharmaceutical, blood product, and diagnostic manufacturing. The company specializes in stable, NaOH-sanitizable affinity chromatography resins, endotoxin-removal products, activated resins, IMAC media, and custom purification solutions. Its patented Direct Capture platform is designed to recover target biomolecules directly from unclarified feed streams, reducing filtration and centrifugation steps and lowering downstream processing costs. Sterogene also offers custom ligand development, purification process development, and contract development and manufacturing services for chromatography resins. The company states that its resins are used in licensed biopharmaceuticals, diagnostic products, and affinity apheresis medical devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sterogene Bioseparations.